36 results
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
5 Jan 24
Results of Operations and Financial Condition
5:01pm
as presented in Q3 earnings release on November 7, 2023. This presentation is not a reaffirmation of guidanc e. Covid - 19 Portfolio Optimization Supply … Chain Challenges $ 5.5M *** $0.4M *** $113.3M $16M 15% $11M 10% $18M 15% 5 Sales and Earnings Trends $102 M $119 M $107.8 M ~$112.3M $111.9 M
Today’s
SD
EX-1.01
m36kw7j
30 May 23
Conflict minerals disclosure
4:17pm
8-K
EX-99.1
oeg83j717n nj
12 Dec 22
Harvard Bioscience Announces CFO Transition
8:31am
8-K
EX-99.1
6le6t13f
8 Nov 22
Harvard Bioscience Announces Third Quarter 2022 Financial Results
4:02pm
8-K
EX-99.1
uyr4qx0
4 Aug 22
Harvard Bioscience Announces Second Quarter 2022 Financial Results
7:01am
SD
EX-1.01
dk9 deznbtf
20 May 22
Conflict minerals disclosure
4:15pm
8-K
EX-99.1
hak9tinkbtln57jydqoo
4 May 22
Harvard Bioscience Announces First Quarter 2022 Financial Results
7:01am
8-K
EX-99.1
n6z1a
8 Mar 22
Harvard Bioscience Announces Fourth Quarter 2021 Financial Results
7:00am